Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Nahon

Showing results (21-30 of 205) with videos related to

Pageof 21
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|February 28, 2021
Epidemiological projections of viral-induced hepatocellular carcinoma in the perspective of WHO global hepatitis eliminationErwan Vo Quang, Yusuke Shimakawa, Pierre Nahon
Hepatobiliary Surgery and Nutrition|September 18, 2018
Percutaneous ablation for HCC eligible to transplantation: providing more opportunities of remission in the context of graft shortageJean-Charles Nault, Pierre Nahon, Olivier Séror
Journal of Hepatology|January 20, 2020
Epidemiology and surveillance for hepatocellular carcinoma: New trendsAmit G Singal, Pietro Lampertico, Pierre Nahon
Journal of Hepatology|August 18, 2020
Reply to: "Challenges associated with the roll-out of HCC surveillance in sub-Saharan Africa - the case of Uganda"Amit G Singal, Pietro Lampertico, Pierre Nahon
Gastroenterologie Clinique Et Biologique|July 10, 2004
[Unexpected protective role of interferon-alpha against Mycobacterium tuberculosis during the course of hepatitis C antiviral therapy]Pierre Nahon, Olivier Brugiere, Patrick Marcellin, et al.
La Revue Du Praticien|March 22, 2013
[Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue]Jean-Claude Trinchet, Pierre Nahon, Nathalie Ganne-Carrie
Liver International : Official Journal of the International Association for the Study of the Liver|December 16, 2024
PNPLA3 in Alcohol-Related Liver DiseaseClélia Galvanin, Stephan Buch, Pierre Nahon, et al.
Journal of Hepatology|December 3, 2014
Reply to: "Hepatic hepcidin expression is decreased in cirrhosis and HCC"Mariia Lunova, Christian Trautwein, Pavel Strnad, et al.
Journal of Clinical Medicine|January 22, 2021
Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV ControlPierre Nahon, Erwan Vo Quang, Nathalie Ganne-Carrié
Hepatology (Baltimore, Md.)|April 6, 2017
ReplyIsabelle Durand-Zaleski, Julie Bulsei, Olivier Seror, et al.
Pageof 21

Showing results (21-30 of 205) with videos related to

Sort By:
Pageof 21
Liver International : Official Journal of the International Association for the Study of the Liver|February 28, 2021
Epidemiological projections of viral-induced hepatocellular carcinoma in the perspective of WHO global hepatitis eliminationErwan Vo Quang, Yusuke Shimakawa, Pierre Nahon
Hepatobiliary Surgery and Nutrition|September 18, 2018
Percutaneous ablation for HCC eligible to transplantation: providing more opportunities of remission in the context of graft shortageJean-Charles Nault, Pierre Nahon, Olivier Séror
Journal of Hepatology|January 20, 2020
Epidemiology and surveillance for hepatocellular carcinoma: New trendsAmit G Singal, Pietro Lampertico, Pierre Nahon
Journal of Hepatology|August 18, 2020
Reply to: "Challenges associated with the roll-out of HCC surveillance in sub-Saharan Africa - the case of Uganda"Amit G Singal, Pietro Lampertico, Pierre Nahon
Gastroenterologie Clinique Et Biologique|July 10, 2004
[Unexpected protective role of interferon-alpha against Mycobacterium tuberculosis during the course of hepatitis C antiviral therapy]Pierre Nahon, Olivier Brugiere, Patrick Marcellin, et al.
La Revue Du Praticien|March 22, 2013
[Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue]Jean-Claude Trinchet, Pierre Nahon, Nathalie Ganne-Carrie
Liver International : Official Journal of the International Association for the Study of the Liver|December 16, 2024
PNPLA3 in Alcohol-Related Liver DiseaseClélia Galvanin, Stephan Buch, Pierre Nahon, et al.
Journal of Hepatology|December 3, 2014
Reply to: "Hepatic hepcidin expression is decreased in cirrhosis and HCC"Mariia Lunova, Christian Trautwein, Pavel Strnad, et al.
Journal of Clinical Medicine|January 22, 2021
Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV ControlPierre Nahon, Erwan Vo Quang, Nathalie Ganne-Carrié
Hepatology (Baltimore, Md.)|April 6, 2017
ReplyIsabelle Durand-Zaleski, Julie Bulsei, Olivier Seror, et al.
Pageof 21